Literature DB >> 10938303

Cocaine and kindling alter the sensitivity of group II and III metabotropic glutamate receptors in the central amygdala.

V Neugebauer1, F Zinebi, R Russell, J P Gallagher, P Shinnick-Gallagher.   

Abstract

G-protein-coupled metabotropic glutamate receptors (mGluRs) are being implicated in various forms of neuroplasticity and CNS disorders. This study examined whether the sensitivities of mGluR agonists are modulated in a distinct fashion in different models of synaptic plasticity, specifically, kindling and chronic cocaine treatment. The influence of kindling and chronic cocaine exposure in vivo was examined in vitro on the modulation of synaptic transmission by group II and III metabotropic glutamate receptors using whole cell voltage-clamp recordings of central amygdala (CeA) neurons. Synaptic transmission was evoked by electrical stimulation of the basolateral amygdala (BLA) and ventral amygdaloid pathway (VAP) afferents in brain slices from control rats and from rats treated with cocaine or exposed to three to five stage-five kindled seizures. This study shows that after chemical stimulation with chronic cocaine exposure or after electrical stimulation with kindling the receptor sensitivities for mGluR agonists are altered in opposite ways. In slices from control rats, group II agonists, (2S,1'S,2'S)-2-(carboxycyclopropyl)glycine (LCCG1) and (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740), depressed neurotransmission more potently at the BLA-CeA than at the VAP-CeA synapse while group III agonist, L(+)-2-amino-4-phosphonobutyrate (LAP4), depressed neurotransmission more potently at the VAP-CeA synapse than at the BLA-CeA. These agonist actions were not seen (were absent) in amygdala neurons from chronic cocaine-treated animals. In contrast, after kindling, concentration response relationships for LCCG1 and LAP4 were shifted to the left, suggesting that sensitivity to these agonists is increased. Except at high concentrations, LCCG1, LY354740, and LAP4 neither induced membrane currents nor changed current-voltage relationships. Loss of mGluR inhibition with chronic cocaine treatment may contribute to counter-adaptive changes including anxiety and depression in cocaine withdrawal. Drugs that restore the inhibitory effects of group II and III mGluRs may be novel tools in the treatment of cocaine dependence. The enhanced sensitivity to group II and III mGluR agonists in kindling is similar to that recorded at the lateral to BLA synapse in the amygdala where they reduce epileptiform bursting. These findings suggest that drugs modifying mGluRs may prove useful in the treatment of cocaine withdrawal or epilepsy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10938303     DOI: 10.1152/jn.2000.84.2.759

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  18 in total

1.  Involvement of group II metabotropic glutamate receptors in stress-induced behavioural sensitization.

Authors:  Rianne Stam; Robert P J de Lange; Haitske Graveland; Peternella S Verhave; Victor M Wiegant
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

Review 2.  Amygdala pain mechanisms.

Authors:  Volker Neugebauer
Journal:  Handb Exp Pharmacol       Date:  2015

Review 3.  Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential.

Authors:  Marion S Mercier; David Lodge
Journal:  Neurochem Res       Date:  2014-08-22       Impact factor: 3.996

4.  Chronic cocaine administration switches corticotropin-releasing factor2 receptor-mediated depression to facilitation of glutamatergic transmission in the lateral septum.

Authors:  Jie Liu; Baojian Yu; Luis Orozco-Cabal; Dimitri E Grigoriadis; Jean Rivier; Wylie W Vale; Patricia Shinnick-Gallagher; Joel P Gallagher
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

5.  Cognitive impairment in pain through amygdala-driven prefrontal cortical deactivation.

Authors:  Guangchen Ji; Hao Sun; Yu Fu; Zhen Li; Miguel Pais-Vieira; Vasco Galhardo; Volker Neugebauer
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

6.  Protein kinase A-dependent enhanced NMDA receptor function in pain-related synaptic plasticity in rat amygdala neurones.

Authors:  Gary C Bird; L Leanne Lash; Jeong S Han; Xiaoju Zou; William D Willis; Volker Neugebauer
Journal:  J Physiol       Date:  2005-03-10       Impact factor: 5.182

7.  Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7.

Authors:  G Sansig; T J Bushell; V R Clarke; A Rozov; N Burnashev; C Portet; F Gasparini; M Schmutz; K Klebs; R Shigemoto; P J Flor; R Kuhn; T Knoepfel; M Schroeder; D R Hampson; V J Collett; C Zhang; R M Duvoisin; G L Collingridge; H van Der Putten
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

Review 8.  Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction.

Authors:  Khaled Moussawi; Peter W Kalivas
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

Review 9.  Group III metabotropic glutamate receptors and drug addiction.

Authors:  Limin Mao; Minglei Guo; Daozhong Jin; Bing Xue; John Q Wang
Journal:  Front Med       Date:  2013-12       Impact factor: 4.592

10.  Olfactory Hallucinations without Clinical Motor Activity: A Comparison of Unirhinal with Birhinal Phantosmia.

Authors:  Robert I Henkin; Samuel J Potolicchio; Lucien M Levy
Journal:  Brain Sci       Date:  2013-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.